Microbial cell surfaces and gastric mucosal microbial targets

Microbial cell surfaces and gastric mucosal microbial targets represent a complex array of molecular structures on the exterior of pathogens, most notably Helicobacter pylori, that colonize the human stomach lining. These targets encompass the bacterial cell wall, outer membrane proteins, and lipopolysaccharides, which are essential for the microbe's structural integrity, nutrient acquisition, and adherence to the gastric epithelium (DrugBank, 2024). In clinical pharmacology, these surfaces serve as the primary site of action for bismuth-containing compounds and various antibiotics used in the treatment of acid-peptic disorders. Drugs such as bismuth subsalicylate interact with these microbial surfaces to induce bacterial lysis, inhibit the production of virulence factors, and prevent colonization (StatPearls, 2023). This interaction is critical for the eradication of H. pylori, which is a major risk factor for the development of chronic gastritis, peptic ulcer disease, and gastric adenocarcinoma (Mayo Clinic, 2023). Additionally, these targets are involved in the sequestration of bacterial toxins, providing a cytoprotective effect to the underlying host tissue.

Other names

Bacterial cell wallGastric microbiotaHelicobacter pylori surface antigensGastric mucosal barrier

Bismuth compounds exert antimicrobial effects by disrupting the microbial cell wall and membrane, inhibiting protein and cell wall synthesis, and preventing bacterial adhesion to the gastric mucosa (StatPearls, 2023).